May 17, 2018
Pfizer invites health care professionals and health care staff to attend an informational program featuring Dr. Joel Galloway from Rockwood Heart and Vascular Center – Downtown.
Treatment Of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) and Reduction In The Risk Of Stroke and Systemic Embolism In Patients With Nonvalvular Atrial Fibrillation (NVAF)
Speaker: Joel Galloway, MD
Sponsored by Pfizer, hosted by Timothy Gallagher.
No CE is offered for this event.
Pharmacists, technicians and student pharmacists are welcome.
Thursday, May 17, 2018
322 North Spokane Falls Court
Spokane, Washington, 99201
This event is free, but you must RSVP.
Registration is closed for this event.
Notice: This event is conducted in accordance with the PhRMA Code on Interactions with Healthcare Professionals (HCPs) and is limited to invited HCPs and appropriate non-HCP staff. Please note that for out-of-office programs, only HCPs (as defined by Pfizer policy) may attend. Before providing an RSVP or attending an out-of-office program, please confirm with your Pfizer representative that you meet the definition of “HCP” and any other requirements of attendance. Attendance by guests or spouses is not appropriate for any Pfizer speaker program unless the individual independently qualifies as an appropriate attendee. In addition, Pfizer policy prohibits attendance by HCPs who practice in a specialty for which the relevant Pfizer product does not have an FDA-approved indication and prohibits attendance by Pfizer speakers who have been trained on the product or topic to be presented.
State and Federal Employees: State and federal laws and regulations may limit your ability to receive meals. By attending this event, you confirm that you have obtained any necessary approvals from your employer.
Public Disclosures: The cost of meals provided to U.S. HCPs is subject to Pfizer’s national public disclosure policy as well as applicable state and federal law such as the National Physician Payment Transparency Program (otherwise known as “Sunshine”). Pfizer’s disclosure allocates the cost of meals equally across all attendees who have not opted out of receiving a meal or have consumed a meal regardless of opt-out status.